Viagra has drastically changed the lives of men the world over. By allowing them to again express themselves sexually, it has made men healthier, happier, and more able to manage their own self esteem. Viagra has undeniably been a major breakthrough in medicine.
But now, researchers are looking for the next drug that will impact sexual health on the same scale. Right now, there are two potential candidates: a drug that will help treat libido problems in women (Flibanserin, which was recently denied on its first review by the FDA), and a drug that will address the widespread problem of premature ejaculation in men. Today, it is thought that as many as 25 to 40 percent of men in the U.S. suffer from premature ejaculation.
A recent market report states that researchers are currently working hard to make a premature ejaculation drug a reality. One drug that the report specifically mentions is Priligy, which Johnson and Johnson plans to release in the EU. Eventually the drug may become available in other countries such as the U.S.
One major challenge that must be overcome by drug manufacturers who dabble in the sexual health market is the privacy issue that must be addressed. Many potential patients who could benefit from these drugs are very apprehensive about talking about them.
It took quite some time for Pfizer to turn Viagra into something that more and more men were willing to discuss with their doctor. Hence, the report maintains that a direct long-term marketing campaign is necessary to make Americans comfortable with a drug that treats premature ejaculation or sexual libido. Of course, some medications are available through the Internet. You don’t even need to speak with a doctor to order Viagra online in some cases.
But, considering the fact that premature ejaculation may affect one in three American men, it makes sense to develop a drug as quickly as possible so that the condition can be treated successfully. It’s very important to develop awareness about premature ejaculation. Hopefully, as a medical solution nears, drug companies will invest in educational outlets for men to take advantage of, with a call to action to address their sexual health issues.
If men are more educated and willing to take action, drug manufacturers will be more willing to invest in research and development without fear of losing money on a risky venture.
Read more health news articles on eDrugstore.com.
We specialize in providing our over 1,000,000 customers with relevant product and condition information created by our professional editorial staff which includes our team of medical writers, medical practitioners, and health educators. eDrugStore.com Staff on Facebook